Deploy $250K as an accredited investor via one of two viable paths: Path A (concentrated) deploys 100% into 1 direct-owned life settlement policy — the entry-tier recommended approach that maximizes the non-correlated diversification anchor with zero fee drag. Path B (lean 3-allocation) splits $250K across LS 60% ($150K), private credit 25% ($62.5K), and liquidity reserve 15% ($37.5K) — suited for investors needing quarterly cash flow during the LS hold period.
Both paths anchor on life settlements because $250K is the exact HYV minimum per policy — this is the tier where direct-ownership LS access unlocks at exactly the accredited entry ticket. Below this level, LS direct ownership isn't accessible without pooled fund vehicles that impose fee drag. Above this level, the deployment strategy shifts toward multi-policy diversification. At exactly $250K, the framework is clean: 1 policy, 2 paths. All returns illustrative and not guaranteed. Available only to accredited investors per SEC Rule 501.
Browse life settlement policies at the $250K entry ticket
Every listing at the $250K per-policy tier includes full documentation — LE reports, AM Best carrier ratings, premium schedules, and projected IRR. See the exact policy that would anchor your entry-tier allocation before you commit anything.
Browse available policiesWhy $250K is the accredited entry tier for direct ownership
$250K holds specific structural significance in the accredited investor landscape. First, it comfortably clears the SEC Rule 501 accredited investor threshold (net worth $1M+ excluding primary residence, or income $200K+ individually / $300K+ jointly over two years). Second, it hits the exact minimum for direct-ownership life settlement acquisitions at HYV — one policy at the entry ticket. Third, it's the tier at which most fee-only fiduciary advisors accept clients, so this is often the capital level at which accredited investors first construct sophisticated alternative allocations rather than staying in pure equity/bond portfolios.
For life settlements specifically, $250K is not just "some capital" — it's the exact institutional access ticket. At smaller capital levels, LS access flows only through pooled fund vehicles with 2-and-20 fee structures that consume 30-40% of gross IRR. At $250K, an accredited individual gains the same direct-ownership approach that Apollo Global Management, Berkshire Hathaway, and Partner Re deploy at institutional scale — same policy sourcing, same LE underwriting standards, same carrier vetting — just at individual-scale ticket size. This is the tier the industry is structured around for individual accredited access.
Two deployment paths are viable at exactly $250K. The choice between them depends on one primary question: does the investor need quarterly cash flow during the 5-10 year LS hold period, or is the investor comfortable with LS returns crystallizing at policy maturity (with cash flow coming from other portions of their broader portfolio)? Path A (concentrated) suits investors treating the $250K as a pure diversification anchor within a larger portfolio. Path B (lean 3-allocation) suits investors treating the $250K as a standalone yield sleeve needing interim income. Both are legitimate — the framework below clarifies the decision.
The two deployment paths for $250K
Below is the side-by-side comparison of both viable $250K deployment paths. Path A is the entry-tier recommended approach for most first-time accredited investors treating $250K as their diversification anchor. Path B is preferred by investors needing regular cash flow during the LS hold period who don't have that income coming from other portfolio positions.
Concentrated single-policy
- Life Settlements $250,000
- Structure 1 direct-owned policy
- Correlation ZERO
- Return crystallization At maturity (5-10 yr)
Split with cash flow
- Life Settlements 60% $150,000
- Private Credit 25% $62,500
- Liquidity Reserve 15% $37,500
- Cash flow Quarterly (PC) + Immediate (Res)
Path selection depends on individual portfolio context, income needs, liquidity requirements, and existing exposure to non-correlated categories. Both paths anchor on life settlements at the $250K entry tier because this is the exact HYV minimum per direct-owned policy. Target IRRs and blended yields are hypothetical and not guaranteed. Individual investor returns vary substantially based on policy characteristics, market conditions, and other factors.
Path A (concentrated) is entry-tier recommended for most first-time accredited investors because it treats $250K as its highest-and-best purpose: acquiring the diversification anchor that traditional portfolios structurally lack. Path B (lean 3-allocation) trades some of that concentration for interim cash flow — a reasonable trade for investors whose $250K is functioning as their yield sleeve rather than as a diversification supplement.
Not sure which path fits your $250K?
Schedule a 20-minute consultation. We'll walk through your income needs, existing portfolio positions, and hold-period tolerance — then recommend Path A or Path B and show 1-2 specific policies matched to your allocation choice.
Or call (833) 250-9677The entry-tier progression ladder: $250K → $500K → $1M
$250K is the entry rung — but not the only rung. Most first-time accredited deployments at $250K eventually grow with additional capital, either through savings accumulation, business exit proceeds, inheritance, or reinvestment of maturing LS positions. The progression ladder below shows how the deployment framework evolves as capital grows through the standard accredited tiers.
6 allocations · 3-policy LE ladder cornerstone + top-quartile PE unlock + institutional real estate + private credit + dividends + reserve. Same structural approach as institutional buyers.
See $1M framework →Projected annual
5 allocations · 2 LS policies cornerstone + real estate syndications + private credit + dividends + reserve. The sweet spot where meaningful diversification kicks in across categories.
See $500K framework →Projected annual
1-3 allocations · exact HYV minimum per policy · Path A concentrated (100% LS single-policy) or Path B lean 3-allocation split. The tier where accredited investors first access institutional-grade alternatives.
Projected annual
Reading the ladder: $250K is the entry rung where LS direct ownership unlocks at the minimum ticket. As capital grows to $500K, the framework expands to 5 allocations with 2 LS policies for meaningful diversification. At $1M, the framework unlocks institutional-tier categories (top-quartile PE, 3-policy LE ladder). The progression is not required — many investors deploy $250K and reinvest maturity payments back into additional policies over time, effectively growing through the tiers organically. Illustrative annual income figures based on hypothetical target IRRs across each tier's balanced scenario. Not guaranteed.
Real walkthrough: James's $250K entry-tier deployment
Here's how the entry-tier framework plays out in practice, illustrated through a composite investor scenario based on the standard pattern for first-time accredited investors deploying exactly $250K at the LS entry ticket.
First-time accredited investor · $250K entry-tier Path A concentrated deployment
Starting position: James, a 52-year-old marketing executive with $1.4M investable, has just formally verified his accredited investor status (net worth over $1M excluding primary residence). His existing $1.4M sits in a traditional 70/30 stock-bond portfolio spread across index funds and target-date allocations. He wants to deploy $250K into his first alternative allocation — specifically to add diversification his existing 70/30 lacks — without adding more of the market exposure he already has.
Path decision: James's advisor walks him through the two-path framework. James already receives quarterly cash flow from his equity and bond positions plus his active employment income, so he doesn't need additional interim cash flow from the $250K. His primary need is diversification — specifically, the zero-correlation LS exposure his existing 70/30 structurally lacks. This maps cleanly to Path A (concentrated single-policy) as the right entry-tier choice for his profile.
Policy selection: James reviews 3 candidate policies presented at his $250K ticket size. He selects a universal life policy from an A+ AM Best rated carrier, with LE from a certified underwriter of 7.3 years, projected IRR at LE of 10.4%, and total death benefit of $520K. Premium schedule fully documented for the 7-year projected hold period.
Acquisition process: James's accredited investor status is verified via SEC Rule 501 documentation (net worth verification via letter from his CPA). Policy assignment paperwork completed over 3 weeks. His name is now on carrier records as owner and beneficiary of the direct-owned policy. Premium schedule established through his brokerage cash account for the projected hold period.
Projected outcome: $250K acquisition + $37K projected premiums over 7-year hold = $287K total invested. Death benefit at maturity: $520K. Net gain projection: $233K ($33K annualized equivalent, ~10.4% IRR). Returns crystallize at policy maturity rather than as ongoing cash flow — during the 7-year hold period, James's existing 70/30 portfolio provides interim income, and the LS position sits as the non-correlated diversification anchor providing structural portfolio value.
Progression plan: James plans to reinvest the $520K maturity payment into 2 additional policies at that point (year 7+), effectively progressing to the $500K balanced tier organically. This is the standard pattern for accredited investors who enter at $250K and grow through the tiers via reinvestment rather than fresh capital injection.
James's $250K deployment reflects the standard first-time accredited pattern: verify accredited status, treat the $250K as a diversification anchor rather than a yield sleeve, select Path A (concentrated single-policy), and plan for organic progression to higher tiers via maturity reinvestment rather than fresh capital. Investors whose $250K is functioning as a standalone yield sleeve (without other portfolio income sources) typically follow Path B (lean 3-allocation) instead, trading some LS concentration for interim quarterly cash flow from private credit and monthly reserve interest.
Get matched with a policy at your $250K entry ticket
Tell us your Path A vs Path B preference, target hold period, and IRR priority. We'll show you 1-2 vetted life settlement policies — matched to your exact $250K deployment — before you commit anything. Full documentation on every listing.
Why direct ownership is the model at the $250K entry tier
The $250K entry tier is where the direct-ownership vs pooled-fund decision becomes most consequential. At larger capital tiers, investors have room to diversify across multiple LS positions even within pooled fund structures. At $250K, every dollar of allocation matters — fee drag of 30-40% on gross IRR (typical for 2-and-20 fund structures over 7-10 year holds) directly compresses the investor's realized return. At exactly the $250K per-policy tier through HYV, direct ownership means the investor's name is on carrier records as owner and beneficiary, gross IRR flows directly to them without fund manager compression, and fee structure is one-time transaction rather than recurring annual drag.
The direct-ownership model is the same institutional approach deployed by Apollo Global Management, Berkshire Hathaway, and Partner Re — accessible for accredited individuals at the exact $250K per-policy entry ticket through HYV. For a complete walkthrough of the direct-ownership acquisition process (LE reports, carrier vetting, policy documentation), see our step-by-step guide to investing in life settlements.
See currently available policies at the entry ticket
Every listing includes full policy documentation, LE reports from certified underwriters, AM Best carrier ratings, premium projections, and projected IRR. Accredited investor verification per SEC Rule 501 required to view specific policies.
Or call (833) 250-9677Frequently asked questions about investing $250K as accredited investor
Is $250K enough to invest in life settlements directly?
Yes — $250K is exactly the direct-ownership entry tier at HYV. It's the minimum ticket per policy, which means at $250K an accredited investor can acquire one direct-owned life settlement policy without needing pooled fund vehicles. Below this level, LS access flows only through fund structures with 2-and-20 fee drag that compresses realized returns. At exactly $250K, the investor's name is on carrier records as owner and beneficiary of an individual policy — the same structural approach institutional buyers use, at individual-scale ticket size. This is why $250K is described as the "accredited entry tier" for LS specifically: it's the smallest capital level where direct-ownership access becomes available with the full institutional structure intact. Above $250K, investors can deploy across multiple policies (2 policies at $500K, 3 policies at $750K+, LE ladder structures at $1M+).
Should I choose Path A concentrated or Path B lean at $250K?
The choice depends on one primary question: does the investor need quarterly cash flow during the 5-10 year LS hold period, or does other portfolio income cover interim cash flow needs? Path A (concentrated 100% LS) is entry-tier recommended for investors treating $250K as a diversification anchor within a larger portfolio — cash flow comes from their other positions and active employment, while the $250K sits as the non-correlated LS exposure their existing portfolio structurally lacks. Path B (lean 3-allocation: LS 60% + private credit 25% + reserve 15%) is preferred by investors whose $250K is functioning as their standalone yield sleeve — they need the private credit's monthly interest and reserve's immediate liquidity because no other portfolio position provides interim distributions. Neither is "better" — they solve different portfolio contexts at the same entry tier.
How do I verify I'm an accredited investor to deploy $250K?
Accredited investor verification under SEC Rule 501 of Regulation D requires meeting one of several criteria: income over $200,000 individually (or $300,000 jointly with spouse) in each of the two most recent years with reasonable expectation of same in current year; OR net worth over $1 million (alone or with spouse, excluding primary residence); OR holding certain professional certifications (Series 7, 65, or 82). Verification typically involves providing supporting documentation to the sponsor: for income-based accreditation, tax returns or W-2s for the last two years; for net worth-based accreditation, a letter from CPA, attorney, or registered investment advisor confirming net worth calculation. Some sponsors accept third-party verification letters from services like VerifyInvestor.com. Under 2020 updates to Rule 506(c), a new safe harbor allows investors who commit at least $200K per investment to self-certify accredited status via written representation — this applies to $250K commitments and simplifies the paperwork significantly.
What annual passive income can $250K generate?
Depending on path selection, projected annual income figures differ. Path A (concentrated single-policy LS at 8-12% target IRR) delivers projected $20K-$30K annual equivalent, but importantly this crystallizes at policy maturity rather than as ongoing cash flow — during the 5-10 year hold period, actual interim cash distributions are zero from the LS position. Path B (lean 3-allocation with LS 60% + private credit 25% + reserve 15%) delivers projected $19K-$25K blended annual income, with actual interim quarterly distributions from private credit (~8% on $62.5K = ~$5K annually) and reserve interest (~4.5% on $37.5K = ~$1.7K annually) totaling ~$6.7K in ongoing cash flow during the LS hold period, plus the LS equivalent yield accrued through maturity. For investors comparing $250K to larger deployments, see our $500K deployment guide ($35K-$51K projected) or $1M deployment guide ($76K-$112K projected).
Is $250K into one life settlement policy too concentrated?
Concentration is a relative concept in portfolio context. Within the $250K allocation itself, yes — Path A concentrates 100% into a single policy without portfolio-level longevity diversification (a single insured life's longevity variance directly affects the entire allocation). Within the investor's TOTAL portfolio context, however, $250K in a single LS policy is typically far from concentrated: for an investor with $1M+ total investable assets deploying $250K into their first alternative allocation, that single LS policy represents 25% of total portfolio, spread across the existing diversified 70/30 equity/bond core plus this new non-correlated LS position. Portfolio-level diversification comes from the LS being uncorrelated to the equity/bond core, not from multiple LS policies. Investors with concentration concerns at the $250K tier typically choose Path B (lean 3-allocation) to spread across LS + private credit + reserve, or defer LS entry until $500K+ capital allows for 2-policy portfolios. Both are valid responses to the concentration question.
Can I grow from $250K entry tier to larger allocations over time?
Yes — this is the standard progression pattern for accredited investors who enter at the $250K tier. Two mechanisms typically drive tier progression: (1) organic growth via LS maturity reinvestment — the $520K+ death benefit received at policy maturity (year 5-10) can be reinvested into 2 additional policies, effectively bringing the investor to the $500K balanced tier ($500K deployment guide framework); (2) fresh capital additions from savings accumulation, business exit proceeds, inheritance, or reinvestment of other portfolio positions. Many first-time accredited investors deploy $250K as their entry, watch the framework work over 3-5 years, then add fresh capital when comfortable — progressing through the tiers organically rather than committing full $500K or $1M upfront. Both approaches are viable. See the entry-tier progression ladder section above for the full framework showing how deployment sophistication evolves from $250K → $500K → $1M with specific allocation frameworks at each tier.
Start at the accredited entry ticket
Two paths to begin: browse currently available life settlement policies to see the exact entry-tier ticket, or schedule a consultation to walk through the Path A vs Path B decision applied to your specific $250K deployment goals.
Or call (833) 250-9677